Top

Chinese Journal of Cancer Research

Published in:

01-12-2010 | Original Article

Apoptotic B16-F1 cells coated with recombinant calreticulin mediated anti-tumor immune response in mice

Authors: Chun-yu Cao, Yu Han, Yu-shan Ren, Yan-lin Wang

Published in: Chinese Journal of Cancer Research | Issue 4/2010

Title: Apoptotic B16-F1 cells coated with recombinant calreticulin mediated anti-tumor immune response in mice
Authors: Chun-yu Cao
Yu Han
Yu-shan Ren
Yan-lin Wang
Publication date: 01-12-2010
Publisher: Chinese Anti-Cancer Association
Published in: Chinese Journal of Cancer Research / Issue 4/2010
Print ISSN: 1000-9604
Electronic ISSN: 1993-0631
DOI: https://doi.org/10.1007/s11670-010-0253-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2010

Interleukin-18 suppresses angiogenesis and lymphangiogenesis in implanted Lewis lung cancer

High expression of ERCC1 is a poor prognostic factor in Chinese patients with non-small cell lung cancer receiving cisplatin-based therapy

Inhibition of proliferation induced by cyclin D1 gene silence in human renal carcinoma ACHN cells

Decrease of peripheral blood CD8+/CD28-suppressor T cell followed by dentritic cells immunomodulation among metastatic breast cancer patients

Methylation and demethylation of Ink4 locus in cancer development

Stanniocalcin-1 detection of peripheral blood in patients with colorectal cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer